FindTrial
Sign In

Safe Propofol Dose for Anaesthesia

Effect site concentration (Ce50) of propofol for I gel insertion using Paedfusor TCI model in paediatric ophthalmologic surgeries. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/05/110565
Enrollment
40
Registered
2026-05-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H00-H59- Diseases of the eye and adnexa

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil Intervention3: Nil: Nil

Sponsors

Postgraduate Institute of Medical Education and Research Chandigarh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Paediatric aged between 3-12 years 2. Patients/Parents/Primary care providers who consent.

Exclusion criteria

Exclusion criteria: 1. Non-consented patient/primary care providers. 2. Allergy to egg 3. URI 4. Co-morbidities related to the heart 5. History of inborn error metabolism of lipids

Design outcomes

Primary

MeasureTime frame
To find the Ce50 of propofol for I-gel insertion with Paedfusor TCI modelTimepoint: Time 0 after I-Gel insertion—

Secondary

MeasureTime frame
To estimate effect site concentration of propofol at which 95% of patients (Ce95) have successful I-gel insertion with Paedfusor TCI modelTimepoint: Time 0 after I-gel insertion;To determine the Cp50 & Cp95 of propofol for I-gel insertion with Paedfusor TCI modelTimepoint: Time 0 after I-Gel insertion—

Countries

India

Contacts

Public ContactDr TANVIR SAMRA

PGIMER, Chandigarh

drtanvirsamra@yahoo.co.in7087262379

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026